United States - English - NLM (National Library of Medicine)

boiron - ipomoea purga root (unii: 4udo46ybk2) (ipomoea purga root - unii:4udo46ybk2) - children's diarrhea or colic* stop use and ask a doctor if symptoms persist for more than 3 days or worsen

United States - English - NLM (National Library of Medicine)

san’up - passiflora incarnata flowering top (unii: clf5yfs11o) (passiflora incarnata flowering top - unii:clf5yfs11o), arabica coffee bean (unii: 3sw678mx72) (arabica coffee bean - unii:3sw678mx72), magnesium (unii: i38zp9992a) (magnesium - unii:i38zp9992a), strychnos ignatii seed (unii: 1nm3m2487k) (strychnos ignatii seed - unii:1nm3m2487k), ipomoea purga root (unii: 4udo46ybk2) (ipomoea purga root - unii:4udo46ybk2), palladium (unii: 5twq1v240m) (palladium - unii:5twq1v240m), tellurium (unii: nqa0o090zj) (t - uses for the temporary relief of symptoms associated with irregular sleep patterns and ordinary restlessness. uses for the temporary relief of symptoms associated with irregular sleep patterns and ordinary restlessness. product ‘uses’ are based on homeopathic materia medica and are not supported by clinical trials. these 'uses' have not been evaluated by the food and drug administration. directions to be taken 10 minutes away from food. invert bottle and shake lightly allowing drops to fall directly under the tongue or into ¼ oz of water. hold contents for about 20 seconds and swallow. to promote drop flow, invert bottle and shake before each use. dosage frequency may be increased up to 6 times daily depending on the severity of symptoms. adults and adolescents (12 years and older) take 10 drops 3 times daily or as recommended by your healthcare practitioner. children (under 12 years) .take under the direction of your healthcare practitioner. stop use and ask a doctor if symptoms persist or worsen.

United States - English - NLM (National Library of Medicine)

physician therapeutics llc - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 50 mg - contraindications trazodone hydrochloride tablets are contraindicated in patients hypersensitive to trazodone hcl. pediatric use safety and effectiveness in the pediatric population have not been established (see box warning and warnings—clinical worsening and suicide risk). anyone considering the use of trazodone hcl in a child or adolescent must balance the potential risks with the clinical need. indications for use sentra pm is intended for the clinical dietary management of the metabolic processes associated with sleep disorders.

United States - English - NLM (National Library of Medicine)

cardinal health - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 100 mg

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 50 mg

United States - English - NLM (National Library of Medicine)

cardinal health - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 50 mg

United States - English - NLM (National Library of Medicine)

watson laboratories, inc. - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - tablet - 50 mg - trazodone hydrochloride is indicated for the treatment of depression. the efficacy of trazodone has been demonstrated in both inpatient and out-patient settings and for depressed patients with and without prominent anxiety. the depressive illness of patients studied corresponds to the major depressive episode criteria of the american psychiatric association’s diagnostic and statistical manual, iii.a major depressive episode implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least four of the following eight symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigability, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and suicidal ideation or attempts. this product is contraindicated in patients hypersensitive to trazodone.

United States - English - NLM (National Library of Medicine)

medvantx, inc. - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 50 mg - trazodone hydrochloride tablets usp are indicated for the treatment of depression. the efficacy of trazodone hydrochloride tablets usp has been demonstrated in both inpatient and outpatient settings and for depressed patients with and without prominent anxiety. the depressive illness of patients studied corresponds to the major depressive episode criteria of the american psychiatric association’s diagnostic and statistical manual, lll.a major depressive episode implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least four of the following eight symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigability, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and suicidal ideation or attempts. trazodone hydrochloride tablets are contraindicated in pa

United States - English - NLM (National Library of Medicine)

dispensing solutions, inc. - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 50 mg - trazodone hydrochloride tablets usp are indicated for the treatment of depression. the efficacy of trazodone hydrochloride tablets usp has been demonstrated in both inpatient and outpatient settings and for depressed patients with and without prominent anxiety. the depressive illness of patients studied corresponds to the major depressive episode criteria of the american psychiatric association’s diagnostic and statistical manual, lll.a major depressive episode implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least four of the following eight symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigability, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and suicidal ideation or attempts. trazodone hydrochloride tablets are contraindicated in

United States - English - NLM (National Library of Medicine)

dispensing solutions, inc. - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 50 mg - trazodone hydrochloride tablets usp are indicated for the treatment of depression. the efficacy of trazodone hydrochloride tablets usp has been demonstrated in both inpatient and outpatient settings and for depressed patients with and without prominent anxiety. the depressive illness of patients studied corresponds to the major depressive episode criteria of the american psychiatric association’s diagnostic and statistical manual, lll.a major depressive episode implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least four of the following eight symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigability, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and suicidal ideation or attempts. trazodone hydrochloride tablets are contraindicated in